194 related articles for article (PubMed ID: 32511789)
41. Pyrvinium doubles against WNT-driven cancer.
Fan J; Reid RR; He TC
J Biol Chem; 2022 Oct; 298(10):102479. PubMed ID: 36096200
[TBL] [Abstract][Full Text] [Related]
42. Type I Interferons Control Proliferation and Function of the Intestinal Epithelium.
Katlinskaya YV; Katlinski KV; Lasri A; Li N; Beiting DP; Durham AC; Yang T; Pikarsky E; Lengner CJ; Johnson FB; Ben-Neriah Y; Fuchs SY
Mol Cell Biol; 2016 Jan; 36(7):1124-35. PubMed ID: 26811327
[TBL] [Abstract][Full Text] [Related]
43. MdmX protects p53 from Mdm2-mediated degradation.
Jackson MW; Berberich SJ
Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
[TBL] [Abstract][Full Text] [Related]
44. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
Ghosh M; Huang K; Berberich SJ
Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
[TBL] [Abstract][Full Text] [Related]
45. Casein kinase 1α has a non-redundant and dominant role within the CK1 family in melanoma progression.
Sinnberg T; Wang J; Sauer B; Schittek B
BMC Cancer; 2016 Aug; 16():594. PubMed ID: 27488834
[TBL] [Abstract][Full Text] [Related]
46. Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.
LeBron C; Chen L; Gilkes DM; Chen J
EMBO J; 2006 Mar; 25(6):1196-206. PubMed ID: 16511560
[TBL] [Abstract][Full Text] [Related]
47. p53 regulation: teamwork between RING domains of Mdm2 and MdmX.
Wang X
Cell Cycle; 2011 Dec; 10(24):4225-9. PubMed ID: 22134240
[TBL] [Abstract][Full Text] [Related]
48. Casein kinase 1α: biological mechanisms and theranostic potential.
Jiang S; Zhang M; Sun J; Yang X
Cell Commun Signal; 2018 May; 16(1):23. PubMed ID: 29793495
[TBL] [Abstract][Full Text] [Related]
49. CK1α suppresses lung tumour growth by stabilizing PTEN and inducing autophagy.
Cai J; Li R; Xu X; Zhang L; Lian R; Fang L; Huang Y; Feng X; Liu X; Li X; Zhu X; Zhang H; Wu J; Zeng M; Song E; He Y; Yin Y; Li J; Li M
Nat Cell Biol; 2018 Apr; 20(4):465-478. PubMed ID: 29593330
[TBL] [Abstract][Full Text] [Related]
50. Autophosphorylation of carboxy-terminal residues inhibits the activity of protein kinase CK1alpha.
Budini M; Jacob G; Jedlicki A; Pérez C; Allende CC; Allende JE
J Cell Biochem; 2009 Feb; 106(3):399-408. PubMed ID: 19115251
[TBL] [Abstract][Full Text] [Related]
51. Targeting the CK1α/CBX4 axis for metastasis in osteosarcoma.
Wang X; Qin G; Liang X; Wang W; Wang Z; Liao D; Zhong L; Zhang R; Zeng YX; Wu Y; Kang T
Nat Commun; 2020 Feb; 11(1):1141. PubMed ID: 32111827
[TBL] [Abstract][Full Text] [Related]
52. Autoinhibition of MDMX by intramolecular p53 mimicry.
Chen L; Borcherds W; Wu S; Becker A; Schonbrunn E; Daughdrill GW; Chen J
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4624-9. PubMed ID: 25825738
[TBL] [Abstract][Full Text] [Related]
53. Constitutive mdmx expression during cell growth, differentiation, and DNA damage.
Jackson MW; Berberich SJ
DNA Cell Biol; 1999 Sep; 18(9):693-700. PubMed ID: 10492400
[TBL] [Abstract][Full Text] [Related]
54. A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.
Rodriguez-Blanco J; Li B; Long J; Shen C; Yang F; Orton D; Collins S; Kasahara N; Ayad NG; McCrea HJ; Roussel MF; Weiss WA; Capobianco AJ; Robbins DJ
Clin Cancer Res; 2019 Feb; 25(4):1379-1388. PubMed ID: 30487124
[TBL] [Abstract][Full Text] [Related]
55. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
[TBL] [Abstract][Full Text] [Related]
56. Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells.
Egorova O; Lau HH; McGraphery K; Sheng Y
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32075226
[TBL] [Abstract][Full Text] [Related]
57. GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction.
Li L; Ren C; Yang G; Fattah EA; Goltsov AA; Kim SM; Lee JS; Park S; Demayo FJ; Ittmann MM; Troncoso P; Thompson TC
Cancer Res; 2011 Dec; 71(24):7694-704. PubMed ID: 22025562
[TBL] [Abstract][Full Text] [Related]
58. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
Okamoto K; Taya Y; Nakagama H
FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
[TBL] [Abstract][Full Text] [Related]
59. MdmX inhibits Smad transactivation.
Kadakia M; Brown TL; McGorry MM; Berberich SJ
Oncogene; 2002 Dec; 21(57):8776-85. PubMed ID: 12483531
[TBL] [Abstract][Full Text] [Related]
60. 14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.
Jin Y; Dai MS; Lu SZ; Xu Y; Luo Z; Zhao Y; Lu H
EMBO J; 2006 Mar; 25(6):1207-18. PubMed ID: 16511572
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
